Qiang Ao

Prof. Qiang Ao

Sichuan University, Chengdu, Sichuan, China
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2020 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
RJRabia Javed
Rabia Javed
MZMuhammad Zia
Muhammad Zia
SNSania Naz
Sania Naz
SASamson O. Aisida
Samson O. Aisida
NANoor Ul Ain
Noor Ul Ain
QAQiang Ao
Qiang Ao
Capping agents are of utmost importance as stabilizers that inhibit the over-growth of nanoparticles and prevent their aggregation/coagulation in colloidal synthesis. The capping ligands stabilize the interface where nanoparticles interact with their medium of preparation. Specific structural features of nanoparticles are attributed to capping on their surface. These stabilizing agents play a key role in altering the biological activities and environmental perspective. Stearic effects of capping agents adsorbed on the surface of nanoparticles are responsible for such changing physico-chemical and biological characteristics. Firstly, this novel review article introduces few frequently used capping agents in the fabrication of nanoparticles. Next, recent advancements in biomedicine and environmental remediation approaches of capped nanoparticles have been elaborated. Lastly, future directions of the huge impact of capping agents on the biological environment have been summarized.

10 May 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
HZHengtong Zhang
Hengtong Zhang
JCJunqiu Cheng
Junqiu Cheng
QAQiang Ao
Qiang Ao
Alginates are naturally occurring polysaccharides extracted from brown marine algae and bacteria. Being biocompatible, biodegradable, non-toxic and easy to gel, alginates can be processed into various forms, such as hydrogels, microspheres, fibers and sponges, and have been widely applied in biomedical field. The present review provides an overview of the properties and processing methods of alginates, as well as their applications in wound healing, tissue repair and drug delivery in recent years.

30 August 2017 in Polymers
Verified
Journal Article
Open access
PDF file
Xiaohong WangXiaohong Wang
Xiaohong Wang
QAQiang Ao
Qiang Ao
XTxiaohong Tian
xiaohong Tian
JFJun Fan
Jun Fan
HTHao Tong
Hao Tong
SBShuling Bai
Shuling Bai
Three-dimensional (3D) bioprinting is a family of enabling technologies that can be used to manufacture human organs with predefined hierarchical structures, material constituents and physiological functions. The main objective of these technologies is to produce high-throughput and/or customized organ substitutes (or bioartificial organs) with heterogeneous cell types or stem cells along with other biomaterials that are able to repair, replace or restore the defect/failure counterparts. Gelatin-based hydrogels, such as gelatin/fibrinogen, gelatin/hyaluronan and gelatin/alginate/fibrinogen, have unique features in organ 3D bioprinting technologies. This article is an overview of the intrinsic/extrinsic properties of the gelatin-based hydrogels in organ 3D bioprinting areas with advanced technologies, theories and principles. The state of the art of the physical/chemical crosslinking methods of the gelatin-based hydrogels being used to overcome the weak mechanical properties is highlighted. A multicellular model made from adipose-derived stem cell proliferation and differentiation in the predefined 3D constructs is emphasized. Multi-nozzle extrusion-based organ 3D bioprinting technologies have the distinguished potential to eventually manufacture implantable bioartificial organs for purposes such as customized organ restoration, high-throughput drug screening and metabolic syndrome model establishment.

1 April 2013 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
XZXiaoyan Zhao
Xiaoyan Zhao
JCJun Chen
Jun Chen
FCFengliang Chen
Fengliang Chen
XWXianchang Wang
Xianchang Wang
QZQingjun Zhu
Qingjun Zhu
QAQiang Ao
Qiang Ao

1 January 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
AMAikeremujiang Muheremu
Aikeremujiang Muheremu
QAQiang Ao
Qiang Ao
With significant advances in the research and application of nerve conduits, they have been used to repair peripheral nerve injury for several decades. Nerve conduits range from biological tubes to synthetic tubes, and from nondegradable tubes to biodegradable tubes. Researchers have explored hollow tubes, tubes filled with scaffolds containing neurotrophic factors, and those seeded with Schwann cells or stem cells. The therapeutic effect of nerve conduits is improving with increasing choice of conduit material, new construction of conduits, and the inclusion of neurotrophic factors and support cells in the conduits. Improvements in functional outcomes are expected when these are optimized for use in clinical practice.

25 January 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
WWWumei Wei
Wumei Wei
QAQiang Ao
Qiang Ao
XWXiaohong Wang
Xiaohong Wang
YCYue Cao
Yue Cao
YLYanying Liu
Yanying Liu
XTxiaohong Tian
xiaohong Tian
As nano-scale biological vesicles, extracellular vesicles (EVs)/exosomes, in particular, exosomes derived from mesenchymal stem cells (MSC-exosomes), have been studied in the diagnosis, prevention, and treatment of many diseases. In addition, through the combination of nanotechnology and biotechnology, exosomes have emerged as innovative tools for the development of nanomedicine. This review focuses on a profound summarization of MSC-exosomes as a powerful tool in bionanomedicine. It systemically summarizes the role of MSC-exosomes as a nanocarrier, drug loading and tissue engineering, and their potential contribution in a series of diseases as well as the advantages of exosomes over stem cells and synthetic nanoparticles and potential disadvantages. The in-depth understanding of the functions and mechanisms of exosomes provides insights into the basic research and clinical transformation in the field of nanomedicine.